Advanced Accelerator Applications SA
LysaKare - Solution for Infusion
LysaKare® 25g/25g solution for reduction of renal (kidney) radiation exposure during peptide-receptor radionuclide therapy with Lutathera®.
LysaKare® 25g/25g solution for reduction of renal (kidney) radiation exposure during peptide-receptor radionuclide therapy with Lutathera®.